SynapSense and Beyond: Where AI Meets Neurodegenerative Disease

What happens when a periodontist from India faces 1,000 rejections, then co-creates an MIT-winning AI tool for early Parkinson’s detection? Dr. Srividya Narayanan’s journey from the dental chair to the frontlines of neuroscience regulation reveals why the people clearing the regulatory path for brain health technology might matter just as much as the scientists building it. Sri joins us to discuss SynapSense, her AI-powered Parkinson’s screening platform, the FDA landscape for neuroscience devices, and why the future of brain health depends on intelligent regulation — not just brilliant science.